- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Seizures of the Lennox-Gastaut syndrome (LGS)
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Cannabidiol – July 2025
Cannabidiol; Oral liquid 100 mg per mL, 100 mL; Epidyolex®
Last updated
9 July 2025